CHOP group achieves temporal control of gene editing with small molecules

As companies home in on ways to temporally control CRISPR/Cas9 gene editing, one academic group thinks small molecule stabilizers could be a solution.

Beverly Davidson, a professor of pathology and laboratory medicine at

Read the full 322 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE